The SCOT Trial (Scleroderma: Cyclophosphamide Or Transplantation) is still recruiting patients who have diffuse scleroderma. The SCOT trials are comparing the potential benefits of stem cell transplant and high-dose monthly cyclophosphamide (Cytoxan) in the treatment of scleroderma. (Also see: SCOT Trial) Reposted 06/05/10.
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Do you have diffuse scleroderma and are between the ages of 18 and 69 (inclusive)?
No replies to this topic